Cited by 23Gastrointestinal motility and disordersCongenital gastrointestinal and neural anomaliesDiabetes Management and Research

Impaired insulin/IGF-1 is responsible for diabetic gastroparesis by damaging myenteric cholinergic neurones and interstitial cells of Cajal

Open access
Yang, Shu, Wu, Bo, Sun, Haimei, Sun, Tingyi, Han, Kai, Li, Dandan, Ji, Fengqing, Zhang, Guoquan +1 more·2017·Bioscience Reports

Abstract

Diabetic gastroparesis is a common complication of diabetes mellitus (DM) that is characterized by decreased serum insulin and insulin-like growth factor-1 (IGF-1). Despite the fact that insulin treatment not glycemic control potently accelerated gastric emptying in type 1 DM patients, the role of insulin/InsR and IGF-1/IGF-1R signaling in diabetic gastroparesis remains incompletely elucidated. In the present study, type 1 DM mice were established and treated with insulin or Voglibose for 8 weeks. The gastric emptying was delayed from DM week 4 when the gastric InsR and IGF-1R were declined. Meanwhile, the gastric choline acetyltransferase (ChAT) was significantly reduced and the myenteric cholinergic neurones and their fibers were significantly diminished. The production of stem cell factor (SCF) was dramatically repressed in the gastric smooth muscles in DM week 6. TWereafter, interstitial cells of Cajal (ICC) were clearly lost and their networks were impaired in DM week 8. Significantly, compared with Voglibose, an 8-week treatment with insulin more efficiently delayed diabetic gastroparesis development by protecting the myenteric cholinergic neurones and ICC. In conclusion, diabetic gastroparesis was an aggressive process due to the successive damages of myenteric cholinergic neurones and ICC by impairing the insulin/InsR and IGF-1/IGF-1R signaling. Insulin therapy in the early stage may delay diabetic gastroparesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bsr20170776

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In diabetes, insulin and IGF-1 deficiency causes muscle atrophy and reduced SCF production, leading to ICC depletion and impaired neuromuscular transmission.

    “In diabetes, insulin and IGF-1 deficiency causes muscle atrophy and reduced SCF production, leading to ICC depletion and impaired neuromuscular transmission [52–60].”

    From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [58]

    The Results section (page unavailable) reports reduced gastric smooth-muscle SCF in diabetic mice at week 6, followed by ICC loss at week 8; the Discussion links these changes to reduced insulin/IGF-1 signaling. The Discussion also identifies ICC as mediators of neuronal transmission, but the paper does not report muscle atrophy or directly demonstrate impaired neuromuscular transmission. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 35 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [1]Nathan D.M. (2015) Diabetes: advances in diagnosis and treatment. JAMA 314, 1052– 1062 26348754
  2. [28]Wu J.J., Rothman T.P. and Gershon M.D. (2000) Development of the interstitial cells of Cajal: origin, Kit dependence and neuronal and nonneuronal sources of Kit ligand. J. Neurosci. Res. 59, 384– 401 10679775

Cited by

Sorted by citations

Authors
Yang, S., Wu, B., Sun, H., Sun, T., Han, K., Li, D., Ji, F., Zhang, G., & Zhou, D.
Affiliations
Capital Medical University (CN)
Corresponding author
  • Zhang, Guoquan
  • Zhou, Deshan
Venue
Bioscience Reports
Published
2017-10-27
Volume
37
Issue
5
ISSN
  • 0144-8463 (ISSN-L)
  • 1573-4935
OpenAlex
W2755494287
Cited by
23
References
35
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 4 · 2018: 4
FWCI
2.59
Type
journal article
Language
en
Open access
Locations
  • Bioscience Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (31371220, 81300285, 81572322)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Surgery › Congenital gastrointestinal and neural anomalies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
diabetic gastroparesis, insulin resistance, insulin-like growth factor I, insulin receptor, IGF1R signaling, interstitial cells of Cajal, choline acetyltransferase, stem cell factor, gastric smooth muscle, gastric emptying, type 1 diabetes, voglibose, insulin therapy
MeSH terms
Animals, Choline O-Acetyltransferase, Disease Models, Animal, Gene Expression Regulation, Humans, Inositol, Insulin, Insulin-Like Growth Factor I, Muscle, Smooth, Receptor, Insulin, Antigens, CD, Mice, Inbred NOD, Receptor, IGF Type 1, Gastroparesis, Stem Cell Factor, Diabetes Complications, Mice, Interstitial Cells of Cajal, Cholinergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review